Valproic acid and augmentation of fetal hemoglobin in individuals with and without sickle cell disease.
Selby
R
R
Nisbet-Brown
E
E
Basran
R K
RK
Chang
L
L
Olivieri
N F
NF
D000755:Anemia, Sickle Cell / Q000097:blood* / Q000150:complications* / Q000628:therapy; D000927:Anticonvulsants / Q000627:therapeutic use*; D000986:Antisickling Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D002220:Carbamazepine / Q000627:therapeutic use; D002648:Child; D005319:Fetal Hemoglobin / Q000096:biosynthesis*; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D012640:Seizures / Q000150:complications* / Q000188:drug therapy*; D014635:Valproic Acid / Q000627:therapeutic use*
D000927:Anticonvulsants; D000986:Antisickling Agents; D006454:Hemoglobins; D002220:Carbamazepine; D014635:Valproic Acid; D005319:Fetal Hemoglobin; D006918:Hydroxyurea